Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback